CLINICAL_TRIALS
trial_result
· 2013-03-12
Clinical Trial Update: A 6-Month Study Of CP-690,550 Versus Tacrolimus In Kidney Transplant Patients [Phase 2]
Summary
A Phase 2 trial compared CP-690,550 (tofacitinib) with tacrolimus in kidney transplant patients, with results posted after completion in 2013.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Pfizer | Conditions: Kidney Transplantation | Phase 2 | Status: COMPLETED | Results posted: 2013-03-12